Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020)
Minerva Neurosciences' (NERV) quarterly Change in Acquisitions & Divestments came in at $3.0 million in Q3 2020, down 91.63% YoY from $35.8 million in Q4 2019, and down 33.33% on a QoQ basis from $4.5 million in Q2 2020.
Analysis
Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020) Analysis & Trends
Minerva Neurosciences (NERV) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $3.0 million in Q3 2020.
- Quarterly Change in Acquisitions & Divestments fell 91.63% year-over-year to $3.0 million in Q3 2020, while the trailing twelve-month figure through Dec 2020 was $28.4 million (down 62.22% YoY) and the FY2020 annual result came in at $28.4 million, down 62.22% from the prior year.
- Change in Acquisitions & Divestments declined to $3.0 million in Q3 2020, from $4.5 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $39.2 million in Q1 2018 to a low of $1.4 million in Q2 2016.
- A 4-year average of $16.5 million and a median of $9.2 million in 2019 frame the typical range for Change in Acquisitions & Divestments.
- The widest YoY moves for Change in Acquisitions & Divestments: up 132.22% in 2020, down 91.63% in 2020.
- Tracing NERV's Change in Acquisitions & Divestments over 4 years: stood at $8.4 million in 2016, then sank by 36.72% to $5.3 million in 2018, then soared by 76.11% to $9.3 million in 2019, then sank by 67.86% to $3.0 million in 2020.
- The last three Change in Acquisitions & Divestments figures came in at $3.0 million (Q3 2020), $4.5 million (Q2 2020), and $20.9 million (Q1 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Minerva Neurosciences | 207.37 Mn | 207.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 4.50 Mn |
| Mar 31, 2020 | 20.90 Mn |
| Dec 31, 2019 | 9.33 Mn |
| Sep 30, 2019 | 35.85 Mn |
| Jun 30, 2019 | 21.00 Mn |
| Mar 31, 2019 | 9.00 Mn |
| Dec 31, 2018 | 5.30 Mn |
| Sep 30, 2018 | 29.50 Mn |
| Jun 30, 2018 | 36.10 Mn |
| Mar 31, 2018 | 39.25 Mn |
| Sep 30, 2016 | 8.38 Mn |
| Jun 30, 2016 | 1.40 Mn |
| Mar 31, 2016 | 8.04 Mn |
| Dec 31, 2015 | 4.05 Mn |